CD163 and colorectal cancer: The infiltration of CD163+ macrophages, indicative of an immunosuppressive M2 phenotype, varied among colorectal cancer (CRC) subtypes, being most prevalent in CMS1 and CMS2/3 (87.0% vs. 61.0%), less prevalent in CMS4, and associated with an intermediate-to-high immunoscore.